Wellfully Limited

Equities

WFL

AU0000105033

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 01:02:13 2023-07-21 am EDT			5-day change	1st Jan Change
0.003 ^AUD	-.--%		-.--%	-.--%

Apr. 08	Wellfully Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
Feb. 29	Wellfully Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Wellfully Limited Announces Bill Pavlovski Steps Down from His Role as Non-Executive Director

June 20, 2023 at 03:56 am EDT

Wellfully Limited announced that Bill Pavlovski has decided to step down from his role as Non-executive Director effective 20 June 2023. Mr. Pavlovski will continue his role as Company secretary and assist the company in its correspondence with the ASX.

Latest news about Wellfully Limited

Wellfully Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Apr. 08	CI
Wellfully Limited Reports Earnings Results for the Full Year Ended June 30, 2023	Feb. 29	CI
Wellfully Limited Announces Bill Pavlovski Steps Down from His Role as Non-Executive Director	23-06-20	CI
Wellfully Limited Announces Board Changes	23-06-09	CI
Wellfully Limited Appoints John Forrester as Director	23-05-17	CI
Wellfully Limited Announces Address Changes	23-05-10	CI
Wellfully Receives R&D Tax Refund	23-04-27	MT
Wellfully Completes AU$1.5 Million Placement	23-04-06	MT
Wellfully Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-04-05	CI
Wellfully Limited Announces Executive Changes	23-03-22	CI
Wellfully Limited Advises Delayed in Reporting its Financial Results for the Six Month Period Ended 31 December 2022	23-02-26	CI
Wellfully Limited announced that it expects to receive AUD 0.26 million in funding from Celtic Capital Pty. Ltd.	23-01-22	CI
Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023	23-01-09	CI
Wellfully Secures Convertible Loan	22-12-29	MT
Wellfully Taps Consulting Firm to Assist in Frankfurt Dual Listing	22-12-29	MT
Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022	22-12-29	CI
Wellfully Signs Pact to Merge Wellness Marketing Company with Self	22-12-06	MT
Wellfully Limited entered into a non-binding memorandum of understanding to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.	22-12-05	CI
Wellfully Limited Appoints Andy Wortlock as Non-Executive Director	22-11-18	CI
Wellfully Seeks Extension of Voluntary Suspension	22-11-16	MT
Wellfully Temporarily Halts Trading	22-11-14	MT
Wellfully Issues More Than 21 Million Ordinary Shares	22-11-04	MT
Wellfully's Lugano-based Facility Receives GMP Certification	22-10-02	MT
Wellfully Limited's Swiss Facility Receives GMP Certification	22-10-02	CI
Wellfully Limited Auditor Raises 'Going Concern' Doubt	22-10-01	CI

Chart Wellfully Limited

Duration

Period

More charts

Company Profile

Wellfully Limited is an Australia-based fully integrated, science-based wellness company. In addition to its own brands, REDUIT and SWISSWELL, the Company also offers a portfolio of technologies and support partners by providing Internet Protocol (IP) and has capabilities in magnetic array design, and claims testing, engineering and production. Its REDUIT brand designs technology-enhanced skincare and haircare treatments, and its technologies include ultrasonic diffusion and magnetic misting. SWISSWELL is a biotechnology brand that offers a technology-enhanced joint management system, the Lubricen Knee Patch. Lubricen is an adhesive knee patch worn on the knee to lubricate the joint before, during and after physical activity. It is focused on both large and small companies across a range of industry and market sectors, including pharmaceutical, cosmetics and skincare, and consumer healthcare.

Sector

Biotechnology & Medical Research

Calendar

2025-02-25 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
WELLFULLY LIMITED	-.--%	964K
IQVIA HOLDINGS INC.	+2.07%	42.75B
LONZA GROUP AG	+47.87%	41.61B
MODERNA, INC.	+12.18%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.03%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.72%	18.12B
MEDPACE HOLDINGS, INC.	+30.13%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.77%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.10%	11B

Other Biotechnology & Medical Research